1. Antazoline for pharmacological cardioversion of atrial fibrillation: the results of the high-volume multicenter CANT study. (25th November 2020) Authors: Wybraniec, M; Maciag, A; Miskowiec, D; Ceynowa-Sielawko, B; Balsam, P; Wrobel, W; Farkowski, M; Cwiek-Rebowska, E; Szolkiewicz, M; Ozieranski, K; Krzowski, B; Kozinski, M; Kasprzak, J; Szwed, H; Mizia-Stec, K Journal: European heart journal Issue: Volume 41:(2020)Supplement 2 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Pharmacological cardioversion of recent-onset atrial fibrillation in patients with chronic kidney disease: sub-analysis of the CANT study. (14th October 2021) Authors: Ceynowa-Sielawko, B; Wybraniec, M; Topp-Zielinska, A; Maciag, A; Miskowiec, D; Krzowski, B; Balsam, P; Wojcik, M; Wrobel, W; Farkowski, M; Kozinski, M; Kasprzak, J; Szwed, H; Mizia-Stec, K; Szolkiewicz, M Journal: European heart journal Issue: Volume 42(2021)Supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗